https://insights.citeline.com/pink-sheet/policy-regulation/us-pharma-tariffs-exemptions-need-more-clarity-impact-varied-EJDAKYPZYNHA7FPUAYAYF3COJU/2026-04-12T20:11:55.222Zalways0.5Insightsen2026-04-12T20:11:55.222Zhttps://insights.citeline.com/resizer/PvehnlJJAt1Q1w45VwWF_DTVdWw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ND5GEZFMFBHPPOYWL7A2UDQ7DA.jpghttps://insights.citeline.com/hbw-insight/health/policy-and-regulation/legislation/direct-to-consumer-advertising-ind-reform-top-us-fdas-wish-list-for-statutory-changes-RKL755OQ7FFPVPP5QVE5CWKPWQ/2026-04-12T18:28:54.643Zalways0.5Insightsen2026-04-12T18:28:54.643Zhttps://insights.citeline.com/resizer/hvz3XCQaNSM9wYnQcBwaGtSqf6w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3GZNN6YOEZDQDJZSFZELYI5K7M.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/gsk-bets-big-on-its-b7-h4-adc-with-five-phase-iii-trials-upcoming-JREV25AGPBCPFNOXOUA2WEKGQM/2026-04-12T14:30:30.576Zalways0.5Insightsen2026-04-12T14:30:30.576Zhttps://insights.citeline.com/resizer/3yz-1BmypmZUymfPjWOBqLK6djs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BKCBDGA2SVCV3EUMMAHFWQ22PQ.jpghttps://insights.citeline.com/companies/lysoway-therapeutics-inc2026-04-12T00:01:24.568Zalways0.5Insightsen2026-04-12T00:01:24.568Zhttps://insights.citeline.com/companies/enara-bio2026-04-12T00:00:55.203Zalways0.5Insightsen2026-04-12T00:00:55.203Z